A Study of 68Ga-Fibroblast Activation Protein Inhibitor (FAPI) Positron Emission Tomography in Heart Failure

Clinical trial NCT07083011 · RECRUITING

Trial details

NCT number: NCT07083011
Sponsor: Mayo Clinic
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Heart Failure With Preserved Ejection Fraction

Start date: 2025-11-01
Primary completion: 2027-07-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.